CAS |
41859-67-0 |
Chinese Name |
苯扎贝特 |
English Name |
Bezafibrate |
Synonyms |
BM15075 |
Molecular Formula |
C19H20ClNO4 |
Molecular Weight |
361.82 |
Solubility |
Soluble in DMSO |
Purity |
HPLC≥98% |
Appearance |
White to off-white Solid |
Storage |
Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC |
EINECS 255-567-9 |
MDL |
MFCD00078970 |
SMILES |
CC(C)(OC1=CC=C(CCNC(C2=CC=C(Cl)C=C2)=O)C=C1)C(O)=O |
InChIKey |
IIBYAHWJQTYFKB-UHFFFAOYSA-N |
InChI |
InChI=1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24) |
PubChem CID |
39042 |
Target Point |
PPAR |
Passage |
Cell Cycle;DNA Damage/DNA Repair;Metabolic Enzyme&Protease |
Background |
Bezafibrate is a PPAR agonist. |
Biological Activity |
Bezafibrate 是 PPAR 的激动剂,对于小鼠PPARα,PPARγ和PPARδ,EC50分别为90μM,55μM,110μM,对于人PPARα,PPARγ和PPARδ分别为50μM,60μM,20μM;Bezafibrate 是一种降血脂剂。[1-3] |
In Vitro |
苯扎贝特(>200μM)显示出对人视网膜微血管内皮细胞(HRMEC)和人视网膜色素上皮ARPE-19细胞的显著细胞毒性。苯扎贝特(30-100μM)抑制肿瘤坏死因子(TNF)α诱导的炎症因子并调节HRMEC中TNFα诱导的核因子(NF)-κB反式激活。苯扎贝特抑制VEGF诱导的HRMECs迁移,并抑制白细胞介素(IL)-1β诱导的ARPE-19细胞VEGF分泌[2]。 |
In Vivo |
苯扎贝特(0.5%)显著降低血浆脂质和葡萄糖水平,并增加TallyHo小鼠胰腺中的胰岛面积。苯扎贝特还可以改善能量消耗和代谢灵活性。此外,苯扎贝特可改善脂肪变性,改善脂质成分,增加肝脏线粒体质量[3]。 |
Cell Experiment |
使用CCK-8试剂盒评估细胞活力。将人类视网膜微血管内皮细胞(HRMEC)或ARPE-19细胞以5000个细胞/孔接种在96孔板中含有10%血清的培养基中。孵育24小时后,将培养基用1%FBS血清饥饿6小时,加入CCK-8试剂,并在三个时间点使用酶标仪在450nm处测量所得溶液的吸光度。用苯扎贝特(0,10,50,100,200,500和1000μM)治疗后24,48和72小时[2]。 |
Animal Experiment |
TallyHo小鼠在我们的动物设施中繁殖。在该研究中仅使用雄性小鼠,并且小鼠接受标准饮食(SD),其为苯扎贝特组补充0.5%(w/w)苯扎贝特8周。通过异氟醚过量杀死动物,并如下所述制备解剖的组织。所有数据均代表苯扎贝特(或SD)治疗8周后取样,除非另有说明[3]。 |
Data Literature Source |
[1]. Willson TM,et al. The PPARs: from orphan receptors to drug discovery. J Med Chem. 2000 Feb 24;43(4):527-50. [2]. Usui-Ouchi A,et al. The peroxisome proliferator-activated receptor pan-agonist bezafibrate suppresses microvascular inflammatory responses of retinal endothelial cells and vascular endothelial growth factor production in retinal pigmented epithelial cells. Int Immunopharmacol. 2017 Nov;52:70-76. [3]. Franko A,et al. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice. Mol Metab. 2017 Jan 6;6(3):256-266. |
Unit |
Bottle |
Specification |
100mg 10mM*1mL in DMSO |